December 2019
Corporate HQ
Ghent, Belgium

Ardena is a leading CDMO providing early stage drug development and manufacturing for small-to-mid-sized biopharma. Ardena’s multi-service platform offers a ‘Make, Analyse, File’ model, whereby services span from drug substance, product manufacturing and bioanalytical services through to regulatory dossier development.

Ardena’s reputation for high science, quality and flexibility has drawn a client base of over 300 customers across Europe, the US, Japan and Korea. Ardena is headquartered in Belgium, operating five other sites across the Netherlands, Sweden and Latvia.

Enablement & Alignment

Shared vision to create a global end-to-end CDMO, with niche capabilities.

Core focus on small molecule development catering to small to mid-size biopharma.

Capability & Capacity

Further cross sell and upsell opportunities to be realized through Ardena’s fully integrated platform.

Significant opportunity to optimize the business development effort for a more integrated approach.

A number of inorganic growth avenues identified in specific adjacencies, including adding upstream capabilities to extend into discovery to take a molecule from target to clinic.

Building Strategic Footprints

Targets identified in the US in order to expand geographic reach.

Expanding sales force presence outside Europe (US office & sales representatives in Asia).